Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1993-6-24
|
pubmed:abstractText |
Ten advanced Parkinson pts (mean 8 years since diagnosis), 6 male and 4 female, 57 to 69 years old, mean 5.9 years on L-Dopa therapy, were put on Madopar HBS to assess the efficacy of the drug. All the pts had levodopa end-of-dose wearing-off type secondary motor fluctuations, 9 of them with dyskinesia and dystonia. Clinical evaluation was performed in basal conditions (pts on standard L-Dopa therapy) 1.6 and 12 months on Madopar HBS therapy. Parkinson signology was quantified with the modified Columbia scale (0 to 44), and motor fluctuations and dyskinesia with a scale 0 to 4 according to intensity and frequency. Pts received mean 1.150 mg. HBS daily dose plus 100 to 200 mg standard L-Dopa added to the early morning dose for a faster effect. At 12 months, a 60% decrease in "off" periods, a 50% decrease in feet dystonia, with no change in orofacial dystonia were observed. Dyskinesia decreased in intensity but not in frequency. There was a 50% decrease of Parkinson signology in "on" periods. In conclusion, Madopar HBS reduces the signology of the long-term Levodopa therapy syndrome and therefore is commendable in pts with advanced Parkinsonism.
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0034-9887
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1022-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1845094-Aged,
pubmed-meshheading:1845094-Benserazide,
pubmed-meshheading:1845094-Drug Administration Schedule,
pubmed-meshheading:1845094-Drug Therapy, Combination,
pubmed-meshheading:1845094-Dyskinesia, Drug-Induced,
pubmed-meshheading:1845094-Female,
pubmed-meshheading:1845094-Humans,
pubmed-meshheading:1845094-Levodopa,
pubmed-meshheading:1845094-Male,
pubmed-meshheading:1845094-Middle Aged,
pubmed-meshheading:1845094-Parkinson Disease,
pubmed-meshheading:1845094-Prospective Studies,
pubmed-meshheading:1845094-Time Factors
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Levodopa and controlled release benserazide in the handling of motor fluctuations in Parkinson's disease].
|
pubmed:affiliation |
Departamento de Medicina, Facultad de Medicina, Universidad de Chile (División Sur), Hospital Bárros Luco-Trudeau, Santiago.
|
pubmed:publicationType |
Journal Article,
English Abstract
|